These changes may be explained by direct or indirect (via purine de novo and salvage metabolism and the homocysteine pathway) effects of MTX. Despite extensive research, the precise mechanism of ...

Tigulixostat (TGX) is a potent and highly selective non-purine based XO inhibitor being investigated for the management of hyperuricemia in patients with gout. Objectives: To evaluate the in vitro and ...